ASX - By Stock
|
CAN |
Re:
Ann: S3 Trial update
|
|
Deb_R
|
73 |
24K |
5 |
21/01/23 |
21/01/23 |
ASX - By Stock
|
73
|
24K
|
5
|
|
ASX - By Stock
|
CAN |
Re:
Ann: S3 Trial update
|
|
Deb_R
|
73 |
24K |
6 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
73
|
24K
|
6
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on capital management timeline
|
|
Deb_R
|
57 |
31K |
4 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
57
|
31K
|
4
|
|
ASX - By Stock
|
CAN |
Re:
Ann: S3 Trial update
|
|
Deb_R
|
73 |
24K |
5 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
73
|
24K
|
5
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Appointment of new CEO
|
|
Deb_R
|
9 |
4.7K |
2 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
9
|
4.7K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on capital management timeline
|
|
Deb_R
|
57 |
31K |
0 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
57
|
31K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on capital management timeline
|
|
Deb_R
|
57 |
31K |
5 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
57
|
31K
|
5
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on capital management timeline
|
|
Deb_R
|
57 |
31K |
11 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
57
|
31K
|
11
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on capital management timeline
|
|
Deb_R
|
57 |
31K |
1 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
57
|
31K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on capital management timeline
|
|
Deb_R
|
57 |
31K |
0 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
57
|
31K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on capital management timeline
|
|
Deb_R
|
57 |
31K |
1 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
57
|
31K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX completes TherapeuticsMD product licensing transaction
|
|
Deb_R
|
44 |
20K |
0 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
44
|
20K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX completes TherapeuticsMD product licensing transaction
|
|
Deb_R
|
44 |
20K |
2 |
09/01/23 |
09/01/23 |
ASX - By Stock
|
44
|
20K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX completes TherapeuticsMD product licensing transaction
|
|
Deb_R
|
44 |
20K |
6 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
44
|
20K
|
6
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
0 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
197
|
74K
|
0
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Deb_R
|
55 |
12K |
0 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
55
|
12K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
3 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
197
|
74K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
8 |
18/12/22 |
18/12/22 |
ASX - By Stock
|
197
|
74K
|
8
|
|
ASX - By Stock
|
MYX |
Re:
General Discussion Topics
|
|
Deb_R
|
336 |
132K |
4 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
336
|
132K
|
4
|
|
ASX - By Stock
|
MDC |
Re:
Ann: NASDAQ Progression - Medlab Clears SEC Comments
|
|
Deb_R
|
14 |
4.2K |
1 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
14
|
4.2K
|
1
|
|
ASX - By Stock
|
MDC |
Re:
Ann: NASDAQ Progression - Medlab Clears SEC Comments
|
|
Deb_R
|
14 |
4.2K |
1 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
14
|
4.2K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
General Discussion Topics
|
|
Deb_R
|
336 |
132K |
4 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
336
|
132K
|
4
|
|
ASX - By Stock
|
MYX |
Re:
General Discussion Topics
|
|
Deb_R
|
336 |
132K |
1 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
336
|
132K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
2 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
197
|
74K
|
2
|
|
ASX - By Stock
|
MDC |
Re:
Ann: NASDAQ Progression - Medlab Clears SEC Comments
|
|
Deb_R
|
14 |
4.2K |
1 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
14
|
4.2K
|
1
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Change of Director's Interest Notice
|
|
Deb_R
|
2 |
1.3K |
1 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
2
|
1.3K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
5 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
197
|
74K
|
5
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
2 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
197
|
74K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
0 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
197
|
74K
|
0
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Port Jackson Securities investor webinar presentation
|
|
Deb_R
|
28 |
14K |
3 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
28
|
14K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
1 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
197
|
74K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
1 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
197
|
74K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
1 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
197
|
74K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
2 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
197
|
74K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
4 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
197
|
74K
|
4
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
6 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
197
|
74K
|
6
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Deb_R
|
55 |
12K |
0 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
55
|
12K
|
0
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Results of Share Purchase Plan offer
|
|
Deb_R
|
13 |
5.3K |
1 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
13
|
5.3K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
0 |
06/12/22 |
06/12/22 |
ASX - By Stock
|
197
|
74K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
4 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
197
|
74K
|
4
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Results of Share Purchase Plan offer
|
|
Deb_R
|
13 |
5.3K |
5 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
13
|
5.3K
|
5
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Deb_R
|
197 |
74K |
4 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
197
|
74K
|
4
|
|
ASX - By Stock
|
MYX |
Re:
Ann: AGM presentation and business and trading update
|
|
Deb_R
|
73 |
35K |
0 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
73
|
35K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
takeover target
|
|
Deb_R
|
40 |
21K |
3 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
40
|
21K
|
3
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Port Jackson Securities investor webinar presentation
|
|
Deb_R
|
28 |
14K |
2 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
28
|
14K
|
2
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Deb_R
|
55 |
12K |
1 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
55
|
12K
|
1
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Share Purchase Plan offer closing date extended
|
|
Deb_R
|
50 |
15K |
2 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
50
|
15K
|
2
|
|
ASX - By Stock
|
MDC |
Re:
Ann: NanoCelle Nasal RNA (Nucleid Acid) Program Update
|
|
Deb_R
|
8 |
2.2K |
0 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
8
|
2.2K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
takeover target
|
|
Deb_R
|
40 |
21K |
2 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
40
|
21K
|
2
|
|
ASX - By Stock
|
MDC |
Re:
Ann: NanoCelle Nasal RNA (Nucleid Acid) Program Update
|
|
Deb_R
|
8 |
2.2K |
0 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
8
|
2.2K
|
0
|
|